Cart
sales@molnova.com
hPL-IN-1
CAS No. 2387374-26-5
hPL-IN-1( —— )
Catalog No. M37035 CAS No. 2387374-26-5
hPL-IN-1 is a potent reversible pancreatic lipase (PL) inhibitor (IC50=1.86 μM) that can be used to study obesity-related diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 193 | In Stock |
|
| 10MG | 276 | In Stock |
|
| 25MG | 430 | In Stock |
|
| 50MG | 581 | In Stock |
|
| 100MG | 768 | In Stock |
|
| 200MG | 1032 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamehPL-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionhPL-IN-1 is a potent reversible pancreatic lipase (PL) inhibitor (IC50=1.86 μM) that can be used to study obesity-related diseases.
-
DescriptionhPL-IN-1 (compound 2t) is a reversible inhibitor of pancreatic lipase (PL) (IC50=1.86 μM) for anti-obesity research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2387374-26-5
-
Formula Weight410.2
-
Molecular FormulaC19H11Cl2F2NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CC=C(OC2=CC=C(Cl)C=C2)C(Cl)=C1)C=3C=C(F)C=C(F)C3O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhao Y, et al. Design, synthesis and biological evaluation of salicylanilides as novel allosteric inhibitors of human pancreatic lipase. Bioorg Med Chem. 2023 Aug 15;91:117413.. .?
molnova catalog
related products
-
Temocapril HCl
Temocapril HCl, the hydrochloride of Temocapril, is a long-acting ACE inhibitor used for the therapy of hypertension.
-
Pyruvic aldehyde
Pyruvic aldehyde (2-Oxopropanal) is a highly reactive dicarbonyl compound that can be converted to lactic acid by evolution from DHA and GLA.
-
TGP-377/421
TGP-377/421 (Targapre-miR-377/421) is a potent dual inhibitor that binds to and inhibits miR-377 and miR-421 at their functional sites.
